Finding a herpes cure has been a long-sought goal. Luckily, there is one that is available. Scientists at Fred Hutchinson Cancer Research Center have been studying the potential for a herpes cure. They are using gene therapy to try to eradicate latent herpes viruses. While the current treatment is hardly perfect, the results are encouraging. Researchers are hopeful that the vaccine will be available in the near future.
There are several types of herpes vaccines available on the market. A vaccine would kill the herpes virus, while a cure would cure the person who is carrying the infection. A cure would heal the person who is carrying the virus, while a vaccine merely prevents it. This is not a cure, however. A cure would heal the person who has the virus, while a vaccine would prevent the virus from infecting other people.
Existing antiviral treatments only treat the symptoms of herpes. This infection is often latent, hiding in the peripheral nerves until it’s time to reactivate it. A cure for herpes should eliminate the pain and spread of the disease. It’s estimated that two-thirds of all people under the age of 50 have herpes. This treatment is effective for type 1 herpes, but scientists haven’t tried it on the type 2 virus yet.
Antiviral medications can reduce the pain and severity of cold sores. They are also effective in keeping the virus from spreading to other people. Antiviral creams with benzyl alcohol and docosanol can be applied directly to the affected area. Afterward, you can apply ice to reduce the pain, which will last several hours. Topical pain relievers with dibucaine, lidocaine, and benzocaine can also be applied to reduce inflammation.
A new technique called gene editing has the potential to be a genital herpes cure. Using a special enzyme called a meganuclease, the enzyme can destroy 90% of the herpes virus in infected cells. The process uses a hollowed-out virus-like particle to deliver the enzyme to the cells. It works much better than CRISPR/Cas9 in killing the herpes virus in mice, according to Jerome.
There are limited treatment options for herpes patients, and most of them have been unsatisfactory. Limited treatment options fail to offer complete relief and are still plagued by the social stigma of infection. With a breakthrough by Synergy Pharmaceuticals, patients can finally look forward to a herpes cure. In the meantime, they can begin the treatment of their other infections. The new treatment will also help them live their lives as normal so that they can focus on their professional and social lives. Get in touch with Herpecillin now.
In addition to using medications, the latest treatment option is a vaccine that teaches the body to reject the herpes virus. Both theraVaxHSV-2 and the GEN-003 vaccine are in clinical trials. While the results of these vaccines are not conclusive, they are a promising solution to herpes. Despite the vaccine, people must avoid sharing their personal items and using communal facilities.
Vaccines are not very effective against hsv2 genital herpes, but scientists hope to find a way to make them more efficient. Some scientists are even working on a vaccine that gathers T-cells to fight the virus. If the vaccine is successful, scientists hope to develop a combined treatment. For example, Professor Akiko Iwasaki at Yale University is working on a vaccine that would trigger the immune system to produce a type of vaccine in response to the infection.